UBS AM’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,103
| Closed | -$130K | – | 2581 |
|
|
2023
Q3 | $130K | Hold |
4,103
| – | – | ﹤0.01% | 2549 |
|
|
2023
Q2 | $422K | Hold |
4,103
| – | – | ﹤0.01% | 2376 |
|
|
2023
Q1 | $422K | Hold |
4,103
| – | – | ﹤0.01% | 2376 |
|
|
2022
Q4 | $601K | Buy |
4,103
+568
| +16% | +$83.2K | ﹤0.01% | 2101 |
|
|
2022
Q3 | $597K | Hold |
3,535
| – | – | ﹤0.01% | 2263 |
|
|
2022
Q2 | $408K | Hold |
3,535
| – | – | ﹤0.01% | 2374 |
|
|
2022
Q1 | $353K | Buy |
3,535
+1,798
| +104% | +$179K | ﹤0.01% | 2553 |
|
|
2021
Q4 | $270K | Hold |
1,737
| – | – | ﹤0.01% | 2702 |
|
|
2021
Q3 | $409K | Hold |
1,737
| – | – | ﹤0.01% | 2557 |
|
|
2021
Q2 | $590K | Buy |
1,737
+154
| +10% | +$52.3K | ﹤0.01% | 2470 |
|
|
2021
Q1 | $640K | Sell |
1,583
-1,144
| -42% | -$463K | ﹤0.01% | 2298 |
|
|
2020
Q4 | $1.81M | Buy |
2,727
+209
| +8% | +$139K | ﹤0.01% | 1723 |
|
|
2020
Q3 | $1.17M | Buy |
2,518
+433
| +21% | +$202K | ﹤0.01% | 1776 |
|
|
2020
Q2 | $1.22M | Buy |
+2,085
| New | +$1.22M | ﹤0.01% | 1718 |
|